Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 10 Jul 20 EFFECT Notice of effectiveness
- 2 Jul 20 POS AM Prospectus update (post-effective amendment)
- 20 Mar 20 EFFECT Notice of effectiveness
- 12 Mar 20 F-1/A Registration statement (foreign) (amended)
-
6 Mar 20 F-1/A Registration statement (foreign) (amended)
- 18 Feb 20 F-1 Registration statement (foreign)
MREO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 29, 2019, in Amendment No. 1 to the Registration Statement (Form F-1 No. 333-236497) and the related Prospectus of Mereo Biopharma Group plc for the registration of 89,510,410 ordinary shares.
/s/ Ernst & Young LLP
London, United Kingdom
March 6, 2020